Compare MGRC & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGRC | BHC |
|---|---|---|
| Founded | 1979 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.5B |
| IPO Year | N/A | N/A |
| Metric | MGRC | BHC |
|---|---|---|
| Price | $106.79 | $6.95 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $147.50 | $8.67 |
| AVG Volume (30 Days) | 118.9K | ★ 2.8M |
| Earning Date | 10-23-2025 | 10-29-2025 |
| Dividend Yield | ★ 1.82% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.90 | 0.97 |
| Revenue | $931,222,000.00 | ★ $10,029,000,000.00 |
| Revenue This Year | $5.46 | $6.81 |
| Revenue Next Year | $4.31 | $4.11 |
| P/E Ratio | $18.07 | ★ $7.15 |
| Revenue Growth | 4.78 | ★ 5.86 |
| 52 Week Low | $94.99 | $4.25 |
| 52 Week High | $129.93 | $8.69 |
| Indicator | MGRC | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 53.15 | 56.07 |
| Support Level | $100.82 | $6.66 |
| Resistance Level | $104.85 | $7.20 |
| Average True Range (ATR) | 2.92 | 0.31 |
| MACD | 1.24 | 0.04 |
| Stochastic Oscillator | 61.70 | 61.71 |
McGrath RentCorp is a rental company. It is comprised of four reportable business segments namely Modular building segment (Mobile Modular); Portable storage container segment (Portable Storage); Electronic test equipment segment (TRS-RenTelco); and its classroom manufacturing business selling modular buildings used as classrooms in California (Enviroplex). The company generates its revenues majorily from the rental of its equipment on operating leases with sales of equipment occurring in the normal course of business.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.